Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Human Psychopharmacology
|
October 10, 2006
Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders
Reiji Yoshimura, Yuichiro Nakano, Hikaru Hori, et al.
Bioinformatics (Oxford, England)
|
July 21, 2004
Application of a new probabilistic model for recognizing complex patterns in glycans
Kiyoko F Aoki, Nobuhisa Ueda, Atsuko Yamaguchi, et al.
Protein Science : a Publication of the Protein Society
|
October 28, 2005
A novel representation of protein sequences for prediction of subcellular location using support vector machines
Setsuro Matsuda, Jean-Philippe Vert, Hiroto Saigo, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 1, 2009
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, et al.
Neuropsychiatric Disease and Treatment
|
April 2, 2009
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura, Nobuhisa Ueda, Hikaru Hori, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
Hikaru Hori, Reiji Yoshimura, Nobuhisa Ueda, et al.
Journal of Clinical Psychopharmacology
|
January 16, 2010
Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels
Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, et al.
Human Psychopharmacology
|
September 23, 2008
Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline
Reiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 12, 2009
Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Human Psychopharmacology
|
October 10, 2006
Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders
Reiji Yoshimura, Yuichiro Nakano, Hikaru Hori, et al.
Bioinformatics (Oxford, England)
|
July 21, 2004
Application of a new probabilistic model for recognizing complex patterns in glycans
Kiyoko F Aoki, Nobuhisa Ueda, Atsuko Yamaguchi, et al.
Protein Science : a Publication of the Protein Society
|
October 28, 2005
A novel representation of protein sequences for prediction of subcellular location using support vector machines
Setsuro Matsuda, Jean-Philippe Vert, Hiroto Saigo, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
April 1, 2009
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression
Reiji Yoshimura, Hikaru Hori, Atsuko Ikenouchi-Sugita, et al.
Neuropsychiatric Disease and Treatment
|
April 2, 2009
Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Nobuhisa Ueda, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 12, 2010
Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients
Reiji Yoshimura, Nobuhisa Ueda, Hikaru Hori, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
July 9, 2008
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder
Hikaru Hori, Reiji Yoshimura, Nobuhisa Ueda, et al.
Journal of Clinical Psychopharmacology
|
January 16, 2010
Nonadherence to paroxetine: a study based on monitoring plasma paroxetine levels
Reiji Yoshimura, Atsuko Ikenouchi-Sugita, Wakako Umene-Nakano, et al.
Human Psychopharmacology
|
September 23, 2008
Addition of risperidone to sertraline improves sertraline-resistant refractory depression without influencing plasma concentrations of sertraline and desmethylsertraline
Reiji Yoshimura, Wakako Umene-Nakano, Nobuhisa Ueda, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 12, 2009
Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine
Atsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, et al.
Page
of 8